JP2003506715A - 色に基づく生化学的及び免疫学的アッセイにおける分光学的測定 - Google Patents
色に基づく生化学的及び免疫学的アッセイにおける分光学的測定Info
- Publication number
- JP2003506715A JP2003506715A JP2001515964A JP2001515964A JP2003506715A JP 2003506715 A JP2003506715 A JP 2003506715A JP 2001515964 A JP2001515964 A JP 2001515964A JP 2001515964 A JP2001515964 A JP 2001515964A JP 2003506715 A JP2003506715 A JP 2003506715A
- Authority
- JP
- Japan
- Prior art keywords
- sample
- color
- cholesterol
- skin
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000005259 measurement Methods 0.000 title claims description 16
- 238000010256 biochemical assay Methods 0.000 title description 3
- 238000010324 immunological assay Methods 0.000 title description 3
- 238000012360 testing method Methods 0.000 claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 52
- 210000003097 mucus Anatomy 0.000 claims abstract description 25
- 239000012491 analyte Substances 0.000 claims abstract description 11
- 238000004458 analytical method Methods 0.000 claims abstract description 11
- 230000005856 abnormality Effects 0.000 claims abstract description 10
- 239000012620 biological material Substances 0.000 claims abstract description 8
- 210000004072 lung Anatomy 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 4
- 210000003756 cervix mucus Anatomy 0.000 claims abstract description 3
- 230000001900 immune effect Effects 0.000 claims abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 148
- 235000012000 cholesterol Nutrition 0.000 claims description 58
- 239000003153 chemical reaction reagent Substances 0.000 claims description 51
- 239000000126 substance Substances 0.000 claims description 37
- 239000000758 substrate Substances 0.000 claims description 33
- 150000001875 compounds Chemical class 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 239000007787 solid Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 238000012800 visualization Methods 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 238000011161 development Methods 0.000 claims description 14
- 238000001514 detection method Methods 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 108010015133 Galactose oxidase Proteins 0.000 claims description 11
- 206010028980 Neoplasm Diseases 0.000 claims description 11
- 201000011510 cancer Diseases 0.000 claims description 9
- 239000003431 cross linking reagent Substances 0.000 claims description 9
- 210000002429 large intestine Anatomy 0.000 claims description 9
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 claims description 8
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical group O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 claims description 8
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 claims description 8
- 230000002159 abnormal effect Effects 0.000 claims description 7
- ADHFZEPOBOTKSO-QLTVFDSQSA-N (1R,2S,4R,5'R,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-3-ol Chemical group O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 ADHFZEPOBOTKSO-QLTVFDSQSA-N 0.000 claims description 6
- 102000003992 Peroxidases Human genes 0.000 claims description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 5
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- 235000014633 carbohydrates Nutrition 0.000 claims description 5
- 239000003365 glass fiber Substances 0.000 claims description 5
- 239000003550 marker Substances 0.000 claims description 5
- 150000002482 oligosaccharides Polymers 0.000 claims description 5
- 238000010186 staining Methods 0.000 claims description 5
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 claims description 4
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 claims description 4
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 claims description 4
- 231100000654 protein toxin Toxicity 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 150000002772 monosaccharides Chemical group 0.000 claims description 3
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 3
- 150000007949 saponins Chemical class 0.000 claims description 3
- 238000004611 spectroscopical analysis Methods 0.000 claims description 3
- 229930002534 steroid glycoside Natural products 0.000 claims description 3
- 241000219745 Lupinus Species 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 239000002459 polyene antibiotic agent Substances 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 210000003103 bodily secretion Anatomy 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 230000003248 secreting effect Effects 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 2
- 238000003556 assay Methods 0.000 description 16
- 239000012528 membrane Substances 0.000 description 13
- 238000002405 diagnostic procedure Methods 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000007689 inspection Methods 0.000 description 8
- 230000028327 secretion Effects 0.000 description 8
- 230000001588 bifunctional effect Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000002798 spectrophotometry method Methods 0.000 description 6
- 239000006260 foam Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 206010009944 Colon cancer Diseases 0.000 description 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000001072 colon Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 210000000664 rectum Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YFNXWBPNBVLTMB-UHFFFAOYSA-N 2-bromo-2-nitro-1,4-dioxane Chemical compound [O-][N+](=O)C1(Br)COCCO1 YFNXWBPNBVLTMB-UHFFFAOYSA-N 0.000 description 2
- KFGWEMFTDGCYSK-UHFFFAOYSA-N 3-methyl-1,2-thiazole 1-oxide Chemical compound CC=1C=CS(=O)N=1 KFGWEMFTDGCYSK-UHFFFAOYSA-N 0.000 description 2
- AXDJCCTWPBKUKL-UHFFFAOYSA-N 4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydron;chloride Chemical compound Cl.C1=CC(=N)C(C)=CC1=C(C=1C=CC(N)=CC=1)C1=CC=C(N)C=C1 AXDJCCTWPBKUKL-UHFFFAOYSA-N 0.000 description 2
- ZRLNBWWGLOPJIC-PYQRSULMSA-N A'-neogammacerane Chemical compound C([C@]1(C)[C@H]2CC[C@H]34)CCC(C)(C)[C@@H]1CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@@H]1C(C)C ZRLNBWWGLOPJIC-PYQRSULMSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 2
- 150000001299 aldehydes Chemical group 0.000 description 2
- -1 and semisolids Substances 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- HDXIQHTUNGFJIC-UHFFFAOYSA-N (25R)-spirost-5-en-3beta-ol 3-O-<O-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranoside> Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O HDXIQHTUNGFJIC-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WRTNFWAEUAKMMA-UHFFFAOYSA-N BrN1N(C(=C(C(=N1)Cl)Cl)Cl)C#N Chemical compound BrN1N(C(=C(C(=N1)Cl)Cl)Cl)C#N WRTNFWAEUAKMMA-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 238000008620 Cholesterol Assay Methods 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- VNONINPVFQTJOC-RXEYMUOJSA-N Collettiside III Natural products O([C@@H]1[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](CO)O[C@@H]1O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]5[C@H](C)[C@@]6(O[C@H]5C4)OC[C@H](C)CC6)CC3)CC=2)CC1)[C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 VNONINPVFQTJOC-RXEYMUOJSA-N 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- GMBQZIIUCVWOCD-UQHLGXRBSA-N Isosarsasapogenin Natural products O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 GMBQZIIUCVWOCD-UQHLGXRBSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 206010057644 Testis cancer Diseases 0.000 description 1
- 206010043515 Throat cancer Diseases 0.000 description 1
- QMGSCYSTMWRURP-UHFFFAOYSA-N Tomatine Natural products CC1CCC2(NC1)OC3CC4C5CCC6CC(CCC6(C)C5CCC4(C)C3C2C)OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(O)C%10O)C8O)C(O)C7O QMGSCYSTMWRURP-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 1
- QXAITBQSYVNQDR-UHFFFAOYSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1N=CN(C)C=NC1=CC=C(C)C=C1C QXAITBQSYVNQDR-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 229940052223 basic fuchsin Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- VNONINPVFQTJOC-ZGXDEBHDSA-N dioscin Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O VNONINPVFQTJOC-ZGXDEBHDSA-N 0.000 description 1
- CJNUQCDDINHHHD-APRUHSSNSA-N dioscin Natural products C[C@@H]1CC[C@@]2(OC1)O[C@H]3C[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@H]6[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O CJNUQCDDINHHHD-APRUHSSNSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 150000002248 furostans Chemical class 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- VNONINPVFQTJOC-UHFFFAOYSA-N polyphyllin III Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C(C1O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C1OC1OC(C)C(O)C(O)C1O VNONINPVFQTJOC-UHFFFAOYSA-N 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- INLFWQCRAJUDCR-LYLBMTSKSA-N spirostane Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 INLFWQCRAJUDCR-LYLBMTSKSA-N 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000010009 steroidogenesis Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 239000013008 thixotropic agent Substances 0.000 description 1
- REJLGAUYTKNVJM-SGXCCWNXSA-N tomatine Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@@]1(NC[C@@H](C)CC1)O5)C)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O REJLGAUYTKNVJM-SGXCCWNXSA-N 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Spectrometry And Color Measurement (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2,279,793 | 1999-08-06 | ||
| CA2279793 | 1999-08-06 | ||
| CA2296163 | 2000-01-17 | ||
| CA2,296,163 | 2000-01-17 | ||
| CA2306315 | 2000-04-20 | ||
| CA2,306,315 | 2000-04-20 | ||
| PCT/CA2000/000918 WO2001011359A2 (en) | 1999-08-06 | 2000-08-04 | Color space analysis in biochemical and immunological assays |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003506715A true JP2003506715A (ja) | 2003-02-18 |
| JP2003506715A5 JP2003506715A5 (enExample) | 2006-01-05 |
Family
ID=27171005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001515964A Pending JP2003506715A (ja) | 1999-08-06 | 2000-08-04 | 色に基づく生化学的及び免疫学的アッセイにおける分光学的測定 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8236516B2 (enExample) |
| EP (1) | EP1218748A2 (enExample) |
| JP (1) | JP2003506715A (enExample) |
| CN (1) | CN1318849C (enExample) |
| AU (1) | AU781034C (enExample) |
| BR (1) | BR0013096A (enExample) |
| WO (1) | WO2001011359A2 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010537193A (ja) * | 2007-08-22 | 2010-12-02 | ファディア・アクチボラグ | 読取方法および読取装置 |
| JP2022546095A (ja) * | 2019-08-29 | 2022-11-02 | アブルカラム ムハンマド シャムスッディーン | 粘膜糖質及び関連状態を検出するスクリーニング方法、デバイス及びキット |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4638608B2 (ja) | 1999-04-09 | 2011-02-23 | リグズホスピタレット | 癌マーカーとしての１型マトリクスメタロプロテイナーゼ組織阻害剤（ｔｉｍｐ−１） |
| US7374886B2 (en) | 1999-04-09 | 2008-05-20 | Rigshospitalet | Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer |
| EP1218748A2 (en) | 1999-08-06 | 2002-07-03 | IMI International Medical Innovations Inc. | Color space analysis in biochemical and immunological assays |
| AU2006217583A1 (en) | 2005-02-28 | 2006-08-31 | Premd Inc. | Method and apparatus for non-invasive measurement of skin tissue cholesterol |
| US20070065893A1 (en) * | 2005-09-19 | 2007-03-22 | Carol Carte | Liquid-phase galactose oxidase-schiff's assay |
| CN100451612C (zh) * | 2007-01-24 | 2009-01-14 | 北京望升伟业科技发展有限公司 | 精子浓度快速诊断试剂盒及其制备和使用方法 |
| CN100451613C (zh) * | 2007-01-24 | 2009-01-14 | 北京望升伟业科技发展有限公司 | 精子浓度快速诊断试剂盒及其制备和使用方法 |
| US20100256464A1 (en) * | 2007-05-14 | 2010-10-07 | Dr. Susan Love Research Foundation | Device for determining risk of developing breast cancer and method thereof |
| CN104181312B (zh) * | 2014-08-08 | 2016-06-01 | 安徽易康达光电科技有限公司 | 一种用于动脉粥样硬化风险评估的皮肤游离胆固醇无创检测装置 |
| US10154813B1 (en) | 2017-07-03 | 2018-12-18 | Spyros Kokolis | Method and apparatus for patient skin color monitoring and drug efficacy measurement |
| US10123738B1 (en) | 2017-07-03 | 2018-11-13 | Spyros Kokolis | Methods and apparatus for skin color patient monitoring |
| LU100486B1 (en) * | 2017-10-20 | 2019-04-25 | Luxembourg Inst Science & Tech List | Automatic water sampler apparatus |
| US10415452B1 (en) * | 2018-03-01 | 2019-09-17 | GM Global Technology Operations LLC | Exhaust gas heat recovery energy extraction strategy |
| ES3036240T3 (en) * | 2019-11-25 | 2025-09-17 | Hoffmann La Roche | Method of determining a concentration of an analyte in a bodily fluid |
| CN111665241B (zh) * | 2020-06-12 | 2023-03-28 | 苏州良辰生物仪器试剂有限公司 | 一种酪氨酸检测试纸条及其制备方法和应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990000251A1 (en) * | 1988-06-30 | 1990-01-11 | Bio-Metric Systems, Inc. | Pressure-assisted analytical apparatus and method |
| JPH09505405A (ja) * | 1993-11-29 | 1997-05-27 | クレピンスキー，ジイリ，ジエイ | 結腸直腸新生物の早期発見用のスクリーニングテスト |
| JPH10185911A (ja) * | 1996-10-23 | 1998-07-14 | K O Denshi Kogyo Kk | 細胞解析装置及びその方法 |
| JP2001513883A (ja) * | 1997-02-20 | 2001-09-04 | アイエムアイ インターナショナル メディカル イノベイションズ インク． | 皮膚組織コレステロールの測定方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3473682A (en) * | 1965-04-08 | 1969-10-21 | Charles E Studen | Drinking utensil jacket |
| JPS53101064A (en) * | 1977-02-15 | 1978-09-04 | Japan Styrene Paper Corp | Apparatus for producing corrugated synthetic resin foamed body |
| US4181765A (en) * | 1978-09-27 | 1980-01-01 | Harmony Richard C | Insulator for canned drinks |
| CA1205731A (en) * | 1982-11-01 | 1986-06-10 | Roger C. Phillips | Test device and method for measurement of analyte levels in colored aqueous fluids |
| US6128516A (en) * | 1994-05-09 | 2000-10-03 | Chromatics Color Sciences International Inc. | Method and apparatus for detecting and measuring conditions affecting color |
| US4898813A (en) * | 1986-04-04 | 1990-02-06 | Albarella James P | Catalytic test composition intended to produce a range of colors |
| US4857457A (en) * | 1986-07-24 | 1989-08-15 | Shamsuddin Abulkalam M | Screening test for large intestinal cancer |
| US5178831A (en) * | 1986-10-08 | 1993-01-12 | Dai Nippon Insatsu Kab Ushiki Kaisha | Device for testing body fluids |
| US4855228A (en) * | 1987-09-11 | 1989-08-08 | Miles Inc. | Multiple oxidative indicator system for visual determination of hydrogen peroxide |
| US5489510A (en) * | 1988-01-19 | 1996-02-06 | 2860601 Canada Inc. | Method for visual indication of cholesterol on skin surface agents used therefor and methods for producing such agents |
| US5162202A (en) | 1989-12-12 | 1992-11-10 | Shamsuddin Abulkalam M | Rectal mucus test and kit for detecting cancerous and precancerous conditions |
| US5348860A (en) | 1988-08-04 | 1994-09-20 | Shamsuddin Abulkalam M | Screening test and kit for cancerous and precancerous conditions |
| GB8825526D0 (en) * | 1988-11-01 | 1988-12-07 | Enzymatix Ltd | Diagnosis |
| US5179288A (en) * | 1991-09-30 | 1993-01-12 | Ortho Pharmaceutical Corporation | Apparatus and method for measuring a bodily constituent |
| JPH07501202A (ja) * | 1991-12-09 | 1995-02-09 | アボツト・ラボラトリーズ | ペルオキシダーゼ及び過酸化物の比色定量 |
| DE4331010A1 (de) * | 1993-09-13 | 1995-03-16 | Jenoptik Jena Gmbh | Meßfühler für spektralphotometrische Remissionsmessungen |
| EP0781404A4 (en) * | 1994-09-14 | 1999-07-21 | X Rite Inc | COMPACT SPECTROPHOTOMETER |
| RU94044169A (ru) * | 1994-12-16 | 1996-10-20 | И.А. Кочетов | Многослойный аналитический элемент |
| JPH08297054A (ja) * | 1995-04-26 | 1996-11-12 | Advantest Corp | 色感測定装置 |
| AU6269196A (en) * | 1995-06-07 | 1996-12-30 | Calgene, Inc. | Cotton fiber transcriptional factors |
| JPH1073491A (ja) * | 1996-08-30 | 1998-03-17 | Kdk Corp | 呈色物定量方法 |
| EP0893690B1 (en) * | 1997-07-14 | 2004-07-14 | Toxi-Test N.V. | Detection of mycotoxins by flow-through membrane-based enzyme immunoassay |
| MXPA00004120A (es) * | 1997-10-31 | 2004-12-02 | Technical Chemicals & Products | Reflectometro. |
| US6464100B2 (en) * | 1998-08-24 | 2002-10-15 | Charles L. Canfield | Container insulator |
| CA2253093A1 (en) * | 1998-11-06 | 2000-05-06 | Jiri J. Krepinsky | Screening test for early detection of colorectal cancer |
| EP1218748A2 (en) | 1999-08-06 | 2002-07-03 | IMI International Medical Innovations Inc. | Color space analysis in biochemical and immunological assays |
| RU2271539C2 (ru) | 2000-04-20 | 2006-03-10 | ПреМД Инк. | Спектрофотометрические измерения в биохимических и иммунологических испытаниях, основанных на наличии окраски |
| US7111753B2 (en) * | 2002-07-30 | 2006-09-26 | Scheetz Ii Thomas J | Insulating sleeve for a beverage container |
| US6814253B2 (en) * | 2002-10-15 | 2004-11-09 | Double Team Inc. | Insulating sleeve for grasping container and manufacturing method |
-
2000
- 2000-08-04 EP EP00954181A patent/EP1218748A2/en not_active Withdrawn
- 2000-08-04 JP JP2001515964A patent/JP2003506715A/ja active Pending
- 2000-08-04 WO PCT/CA2000/000918 patent/WO2001011359A2/en not_active Ceased
- 2000-08-04 AU AU66734/00A patent/AU781034C/en not_active Ceased
- 2000-08-04 BR BR0013096-6A patent/BR0013096A/pt not_active Application Discontinuation
- 2000-08-04 CN CNB008134979A patent/CN1318849C/zh not_active Expired - Fee Related
-
2004
- 2004-07-09 US US10/887,737 patent/US8236516B2/en not_active Expired - Fee Related
-
2012
- 2012-07-05 US US13/542,125 patent/US8712491B2/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990000251A1 (en) * | 1988-06-30 | 1990-01-11 | Bio-Metric Systems, Inc. | Pressure-assisted analytical apparatus and method |
| JPH09505405A (ja) * | 1993-11-29 | 1997-05-27 | クレピンスキー，ジイリ，ジエイ | 結腸直腸新生物の早期発見用のスクリーニングテスト |
| JPH10185911A (ja) * | 1996-10-23 | 1998-07-14 | K O Denshi Kogyo Kk | 細胞解析装置及びその方法 |
| JP2001513883A (ja) * | 1997-02-20 | 2001-09-04 | アイエムアイ インターナショナル メディカル イノベイションズ インク． | 皮膚組織コレステロールの測定方法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010537193A (ja) * | 2007-08-22 | 2010-12-02 | ファディア・アクチボラグ | 読取方法および読取装置 |
| US8611619B2 (en) | 2007-08-22 | 2013-12-17 | Phadia Ab | Read-out method and apparatus |
| JP2022546095A (ja) * | 2019-08-29 | 2022-11-02 | アブルカラム ムハンマド シャムスッディーン | 粘膜糖質及び関連状態を検出するスクリーニング方法、デバイス及びキット |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1218748A2 (en) | 2002-07-03 |
| CN1318849C (zh) | 2007-05-30 |
| WO2001011359A2 (en) | 2001-02-15 |
| US20050003468A1 (en) | 2005-01-06 |
| HK1053702A1 (en) | 2003-10-31 |
| US8712491B2 (en) | 2014-04-29 |
| AU6673400A (en) | 2001-03-05 |
| BR0013096A (pt) | 2002-05-07 |
| CN1399723A (zh) | 2003-02-26 |
| US8236516B2 (en) | 2012-08-07 |
| AU781034B2 (en) | 2005-04-28 |
| WO2001011359A9 (en) | 2002-08-29 |
| AU781034C (en) | 2006-05-11 |
| US20120277553A1 (en) | 2012-11-01 |
| WO2001011359A3 (en) | 2001-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8712491B2 (en) | Measurement of an analyte on the skin using a hue angle | |
| EP0171150A2 (en) | Method and apparatus for assaying with optional reagent quality control | |
| CN102135535B (zh) | 一种直接进行半定量分析的免疫胶体金属检测技术及其制备方法和用途 | |
| AU2005238099B2 (en) | Direct assay of skin cholesterol in skin samples removed by tape stripping | |
| US8690792B2 (en) | Direct assay of cholesterol in skin removed by tape stripping | |
| US20110065139A1 (en) | diagnostic device for identifying rupture of membrane during pregnancy | |
| US20080188387A1 (en) | Direct Assay of Skin Protein in Skin Samples Removed by Tape Stripping | |
| US5935775A (en) | Whole blood analysis of prostate specific antigen spotted on a solid support | |
| US6051393A (en) | Method of detecting malignant and pre-malignant conditions of the cervix, and test kits therefor | |
| US20130177485A1 (en) | Diagnostic device for identifying rupture of membrane during pregnancy | |
| EP2198299A2 (en) | A diagnostic device for identifying rupture of membrane during pregnancy | |
| US7238494B2 (en) | Direct assay of cholesterol in skin samples removed by tape stripping | |
| RU2271539C2 (ru) | Спектрофотометрические измерения в биохимических и иммунологических испытаниях, основанных на наличии окраски | |
| Liu et al. | Prediction of fetal lung maturity from near‐infrared spectra of amniotic fluid | |
| CN112129954B (zh) | Mmp7、ctse或lamc2蛋白在制备肝内胆管细胞癌诊断试剂中的应用 | |
| HK1053702B (en) | Spectrophotometric measurement in color-based biochemical and immunologigal assays | |
| US20090110641A1 (en) | Method and apparatus for non-invasive measurement of skin tissue cholesterol | |
| CN101082628A (zh) | 以颜色为基础的生化和免疫分析中的光谱测量 | |
| RU2002103517A (ru) | Спектрофотометрические измерения в биохимических и иммунологических испытаниях, основанных на наличии окраски | |
| Odiabara | Assessment of Salivary Creatinine and Urea as Non-Invasive Alternatives to Serum Markers in Healthy Individuals | |
| CA2817639A1 (en) | Direct assay of skin cholesterol in skin samples removed by tape stripping | |
| KR20230072832A (ko) | 인간의 소변을 검체로 이용하여 대장암을 진단하는 진단키트 | |
| Scott et al. | Melanogenuria: laboratory evaluation of the qualitative Thormählen and ferric chloride tests and their clinical utility. | |
| LIGHT | GGS are always free of detergents and other contaminants. Some substances can interfere with patient results. Contamination of the urine specimen with skin cleansers containing chlorhexidine may affect protein test results. The user |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050224 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050811 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070724 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091110 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100406 |